20 clinical trials matched your search for Multiple Myeloma. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Multiple Myeloma A study for patients with relapsed of refractory multiple myeloma using study drug KPT-330 Suzanne Lentzsch, MD
Multiple Myeloma Study of Drug in Subjects with Multiple Myeloma Suzanne Lentzsch, MD
Multiple Myeloma Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma (KarMMa-2) Ran Reshef, MD
Multiple Myeloma First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma Suzanne Lentzsch, MD
Multiple Myeloma Study of PBCAR269A in Participants With Relapsed/Refractory Multiple Myeloma Ran Reshef, MD
Multiple Myeloma Safety and Efficacy of Bb2121 (Ide-cel) Combinations in Patients with Multiple Myeloma (KarMMa-7) Ran Reshef, MD
Multiple Myeloma Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant Divaya Bhutani, MD
Multiple Myeloma Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM) Rajshekhar Chakraborty, MD
Multiple Myeloma Study of VRd Followed by Cilta-cel vs. VRd Followed by Rd Therapy in Patients with Newly Diagnosed Multiple Myeloma Ran Reshef, MD
Cancer Tissue Repository For The Collection of Hematologic Samples Suzanne Lentzsch, MD
Cancer Early Onset Malignancies Initiative (EOMI) Matthew Ingham, MD
Brain Tumors A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Andrew Lassman, MD
Cancer Smartphone App for Cancer Medication Adherence Melissa Accordino, MD
Blood Disorders Screening to Improve Survival in AL Amyloidosis Suzanne Lentzsch, MD
Cancer Study of New Oral Anti-Cancer Drug (OACD) Dawn Hershman, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Cancer Study of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) Divaya Bhutani, MD
Lymphoma Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant Divaya Bhutani, MD
Brain Cancer A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Andrew Lassman, MD
Cancer ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma Ran Reshef, MD